These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2683537)

  • 21. A semiclosed-loop optimal control system for blood glucose level in diabetics.
    Ibbini MS; Masadeh MA; Amer MM
    J Med Eng Technol; 2004; 28(5):189-96. PubMed ID: 15370997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
    Garg SK; Gottlieb PA; Hisatomi ME; D'Souza A; Walker AJ; Izuora KE; Chase HP
    Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus.
    Dahl-Jørgensen K; Bjøro T; Kierulf P; Sandvik L; Bangstad HJ; Hanssen KF
    Kidney Int; 1992 Apr; 41(4):920-3. PubMed ID: 1513113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved diabetic control in adolescents using the Penject syringe for multiple insulin injections.
    McCaughey ES; Betts PR; Rowe DJ
    Diabet Med; 1986 May; 3(3):234-6. PubMed ID: 2951175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
    Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.
    Pfützner A; Hermanns N; Funke K; Forst T; Behnke T; Bitton G; Nagar R; Raz I; Haak T
    Curr Med Res Opin; 2014 May; 30(5):753-60. PubMed ID: 24392996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. V-Go Insulin Delivery System Versus Multiple Daily Insulin Injections for Patients With Uncontrolled Type 2 Diabetes Mellitus.
    Winter A; Lintner M; Knezevich E
    J Diabetes Sci Technol; 2015 Apr; 9(5):1111-6. PubMed ID: 25904143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.
    Home PD; Lindholm A; Hylleberg B; Round P
    Diabetes Care; 1998 Nov; 21(11):1904-9. PubMed ID: 9802741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of diabetics with the use of a microprocessor: comparison of insulin treatments based on blood and urine glucose levels.
    Hermányi I; Tamás G
    Acta Diabetol Lat; 1988; 25(1):33-40. PubMed ID: 3043988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
    Scheen AJ; Letiexhe MR; Lefèbvre PJ
    Diabetes Metab; 1999 Jun; 25(2):157-62. PubMed ID: 10443327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study.
    Valentini M; Scardapane M; Bondanini F; Bossi A; Colatrella A; Girelli A; Ciucci A; Leotta S; Minotti E; Pasotti F; Pesenti A; Rocca L; Sciangula L; Vavassori E; Nicolucci A
    Curr Med Res Opin; 2015 Mar; 31(3):487-92. PubMed ID: 25469829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation.
    Davidson PC; Steed RD; Bode BW
    Diabetes Care; 2005 Oct; 28(10):2418-23. PubMed ID: 16186273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial.
    Soliman AT; Omar M; Rizk MM; El Awwa A; AlGhobashy FM
    J Trop Pediatr; 2006 Aug; 52(4):276-81. PubMed ID: 16410276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Software-guided insulin dosing: tight glycemic control and decreased glycemic derangements in critically ill patients.
    Saur NM; Kongable GL; Holewinski S; O'Brien K; Nasraway SA
    Mayo Clin Proc; 2013 Sep; 88(9):920-9. PubMed ID: 24001484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin dosage adjustment in diabetes.
    Lehmann ED; Deutsch T
    J Biomed Eng; 1992 May; 14(3):243-9. PubMed ID: 1588782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study).
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Pehrsson NG; Moström P
    J Diabetes Sci Technol; 2016 May; 10(3):754-61. PubMed ID: 27081191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computer-assisted insulin dosage adjustment.
    Schiffrin A; Mihic M; Leibel BS; Albisser AM
    Diabetes Care; 1985; 8(6):545-52. PubMed ID: 3908025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.